《沪深两市》上证深成半日跌0.6%-0.7% 资源股回调 中医药股造高
中国央行公开市场进行100亿元人民币(下同)7天期逆回购操作。人民币兑美元中间价下调。上证深成低开後跌幅逐步收窄。创板曾拗腰倒升。
上证半日跌0.7%或25点，收报3,437点；深成跌83点或0.6%，收报13,981点；沪深300指数跌40点或0.8%，收报5,003点；创业板指数曾倒升，半日微跌6点或0.2%，收报2,953点，成交934亿元。沪深两市成交分别为2,188亿元及2,818亿元。
中资金融股偏软，工行(601398.SH)、中国平安(601318.SH)、建行(601939.SH)跌0.6%-0.8%。
汽车股回吐，比亚迪(002594.SZ)跌2.6%。公司上日公布拟将比亚迪半导体分拆至深交所创业板上市。长汽(601633.SH)跌3%。
资源股回调，钢铁股普遍受压，重庆钢铁(601005.SH)、太钢不锈(000825.SZ)、八一钢铁(600581.SH)跌2.8%-7.2%。海南矿业(601969.SH)、云铝股份(000807.SZ)、神火股份(000933.SZ)、潞安环能(601699.SH)、西部矿业(601168.SH)、江西铜业(600362.SH )跌4.7%-9.3%。
医美、眼科医疗概念股走高，金发拉比(002762.SZ)、景峰医药(000908.SZ)、开能健康(300272.SZ)升3%-9%。东宝生物(300239.SZ)涨12.2%。方盛制药(603998.SH)、莱美药业(300006.SZ)、爱博医疗(688050.SH)升3.2%-7.9%。
中医药股造高，葫芦娃(605199.SH)、西藏药业(600211.SH)、华神科技(000790.SZ)涨停。同仁堂(600085.SH)扬6.1%。国家主席习近平提倡要发展中医药，注重用现代科学解读中医药学原理，走中西医结合的道路。
公牛集团(603195.SH)跌4.9%。浙江省市场监督管理局对公司涉嫌实施垄断协议行为进行立案调查。(ta/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
